PhysEmp :: Medicine :: Medical Specialties :: Ophthalmology (86)

All Ophthalmology Jobs

Permanent Ophthalmology Job in Massillon Ohio with Community Health Systems, Inc
A retiring physician is ready to turn over a ready made practice to a talented general Ophthalmologist or someone specialty trained in glaucoma, oculoplastics or pediatrics. Two prime office locations
Permanent Ophthalmology Job in Williamsport Pennsylvania with Susquehanna Health
Susquehanna Health is seeking an Ophthalmologist to join one (1) other in our practice and two (2) others that are in private practice here in Williamsport, Pennsylvania. Be part of the team that is
Permanent Ophthalmology Job in Not Disclosed Nevada with Locum Medical Group
The VA is in need of an Ophthalmologist for their facility in Reno, Nevada. The assignment will begin in September and will continue for three months. A NV medical license is not required for this opportunity.

Current Opinion in Ophthalmology - Current Table Of Contents

Editorial introductions.
Page: viDOI: 10.1097/ICU.0b013e328311f053
Pediatric strabismus imaging.
Page: 371DOI: 10.1097/ICU.0b013e328309f165Authors: Kadom, Nadja
Recent developments in the field of superior oblique palsies.
Page: 379DOI: 10.1097/ICU.0b013e328309f191Authors: Madigan, William P; Zein, Wadih M

Archives of Ophthalmology current issue

ABOUT THIS JOURNAL: About This Journal
Mon, 11 Aug 2008 00:00:00 -0000

CLINICAL TRIAL: Canadian Glaucoma Study: 2. Risk Factors for the Progression of Open-angle Glaucoma
Chauhan, B. C., Mikelberg, F. S., Balaszi, A. G., LeBlanc, R. P., Lesk, M. R., Trope, G. E., for the Canadian Glaucoma Study Group Mon, 11 Aug 2008 00:00:00 -0000
Objective  To determine systemic and ocular risk factors for visual field progression in open-angle glaucoma. Methods  In the Canadian Glaucoma Study, a multicenter prospective longitudinal study of 258 patients (131 men and 127 women; median age, 65.0 years), baseline systemic measures included assessment of peripheral vasospasm and markers for hematopathology, coagulopathy, and immunopathology. Patients were followed up at 4-month intervals with perimetry, optic disc imaging, and a standardized interventional protocol for intraocular pressure control. Univariate and proportional hazards models were used to identify factors that predicted progression. Main Outcome Measure  Visual field progression with standard automated perimetry. Results  Median follow-up was 5.3 years, with 167 patients (64.7%) completing 5 years or more and 67 patients (26.0%) completing 7 years or more. Abnormal baseline anticardiolipin antibody levels (hazard ratio [HR], 3.86; 95% confidence interval [CI], 1.60-9.31), higher baseline age (HR per year, 1.04; 95% CI, 1.01-1.07), female sex (HR, 1.94; 95% CI, 1.09-3.46), and higher mean follow-up intraocular pressure (HR per 1 mm Hg, 1.19; 95% CI, 1.05-1.36) before progression were associated with progression. Conclusions  The Canadian Glaucoma Study identified 4 independent predictive factors for glaucomatous field progression. Application to Clinical Practice  While confirming the importance of intraocular pressure in glaucoma progression, this study determined other risk factors that merit awareness. Trial Registration  clinicaltrials.gov Identifier: NCT00262626
CLINICAL TRIAL: A Randomized Trial of Atropine vs Patching for Treatment of Moderate Amblyopia: Follow-up at Age 10 Years
Pediatric Eye Disease Investigator Group Mon, 11 Aug 2008 00:00:00 -0000
Objective  To determine the visual acuity outcome at age 10 years for children younger than 7 years when enrolled in a treatment trial for moderate amblyopia. Methods  In a multicenter clinical trial, 419 children with amblyopia (visual acuity, 20/40-20/100) were randomized to patching or atropine eyedrops for 6 months. Two years after enrollment, a subgroup of 188 children entered long-term follow-up. Treatment after 6 months was at the discretion of the investigator; 89% of children were treated. Main Outcome Measure  Visual acuity at age 10 years with the electronic Early Treatment Diabetic Retinopathy Study test. Application to Clinical Practice  Patching and atropine eyedrops produce comparable improvement in visual acuity that is maintained through age 10 years. Results  The mean amblyopic eye acuity, measured in 169 patients, at age 10 years was 0.17 logMAR (logarithm of the minimum angle of resolution) (approximately 20/32), and 46% of amblyopic eyes had an acuity of 20/25 or better. Age younger than 5 years at entry into the randomized trial was associated with a better visual acuity outcome (P < .001). Mean amblyopic and sound eye visual acuities at age 10 years were similar in the original treatment groups (P = .56 and P = .80, respectively). Conclusions  At age 10 years, the improvement of the amblyopic eye is maintained, although residual amblyopia is common after treatment initiated at age 3 years to younger than 7 years. The outcome is similar regardless of initial treatment with atropine or patching. Trial Registration  clinicaltrials.gov Identifier: NCT00000170

Subscribe to Ophthalmology RSS feed